Organisation paid for research Program year 2025 Source: CMS Open Payments

Central Valley Research LLC

Neither a doctor nor a teaching hospital

Research payments

$2,259,003

46 payments

Through program year 2025, Central Valley Research LLC is reported as receiving $2,259,003 in research payments, across 46 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$183,629	12
2024	Research	$344,220	19
2023	Research	$264,852	8
2022	Research	$17,371	2
2021	Research	$875,143	4
2020	Research	$573,789	1

Breakdown

Who paid Research payments · program years 2020–2025

Eli Lilly and Company $1,460,303 6 payments
GlaxoSmithKline, LLC. $798,700 40 payments

Studies the money was for Research payments · program years 2020–2025

A Randomized, Double Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Ly3819253 and Ly3832479 in Participants With Mild to Moderate Covid-19 Illness $1,016,354 4 payments
A Double-Blind, Double Dummy, Randomized, Phase 1B, Nitrofurantoin Con $590,139 20 payments
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate Covid-19 Illness (Blaze-4) $443,948 2 payments
A Phase III, Open-Label, Randomized, Controlled, Multi-Country Study T $139,533 14 payments
A Phase 3B, Open-Label, Single-Arm Study in Adolescent and Adult Femal $63,028 5 payments
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, DO $6,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.